Your Account
Sort
Categories
- #EMSPVirtual2021
- Associate members
- Document
- EMSP Events
- EMSP Events|EMSP News
- EMSP News
- EMSP News|From Europe
- EMSP News|From Europe|Stakeholder Events
- EMSP News|MS Research
- EMSP News|Press Releases
- EMSP News|Young People with MS
- From Europe
- From Europe|Member News
- From Europe|Stakeholder Events
- From Europe|Young People with MS
- Full members
- Full members|Member News
- Member News
- Member News|Young People with MS
- MS Research
- News – EMSP
- Press Releases
- Stakeholder Events
- Uncategorized
- Young People with MS
Ready for Work social media campaign: 140,000 people reached
EMSP thanks all its partners and supporters who contributed to our successful social media ‘Thunderclap’ campaign around our new Ready…
European Medicines Agency: Treatment Updates
Health education and safety are key to MS management, and this is why EMSP is encouraging its MS community to regularly consult the website…
European Medicines Agency: Treatment Updates
The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU). The Agency is responsible for the scientific evaluation, supervision and safety monitoring of medicines developed by pharmaceutical companies for use in the EU.
EMSP handover. Outgoing CEO: I leave the organisation in an excellent state
The European Multiple Sclerosis Platform’s (EMSP) outgoing Chief Executive (CEO) Maggie Alexander handed over the reins in late March to…
EMSP handover. Outgoing CEO: I leave the organisation in an excellent state
The European Multiple Sclerosis Platform’s (EMSP) outgoing Chief Executive (CEO) Maggie Alexander handed over the reins in late March to…
Croatia: Guinness record-chasing MS Youth Club campaigned for rare diseases with photo collection of hugs
A group of young people living with multiple sclerosis (MS) in Croatia achieved local and national media coverage by raising…
EMA to bolster support for medicines targeting unmet medical needs
The European Medicines Agency (EMA) has launched, on 7 March, a scheme designed to strengthen support to medicines that target an unmet medical need – EMA Prime.
